Neurocrine Biosciences, Inc. (NBIX)
133.34
-1.99
(-1.47%)
USD |
NASDAQ |
Jan 15, 16:00
133.34
0.00 (0.00%)
After-Hours: 19:34
Neurocrine Biosciences SG&A Expense (TTM): 1.142B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Masimo Corp. | 596.30M |
| Insulet Corp. | 1.094B |
| Marker Therapeutics, Inc. | 4.365M |
| CapsoVision, Inc. | 10.68M |